NCT00050830 A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00050401 Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia Requiring Mechanical Ventilatory Support Status COMPLETED Phase PHASE3
NCT00043394 CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00043368 PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909) Status COMPLETED Phase PHASE2
NCT00041704 The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC) Status COMPLETED Phase PHASE2
NCT00040391 A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer Status TERMINATED Phase PHASE2
NCT00040014 Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal Women Status TERMINATED Phase PHASE2
NCT00039910 Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia Status COMPLETED Phase PHASE3
NCT00038467 Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer Status COMPLETED Phase PHASE3
NCT00038311 Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia Status COMPLETED Phase PHASE3
NCT00038103 Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen Status COMPLETED Phase PHASE2
NCT00037804 Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction Status COMPLETED Phase PHASE1
NCT00037791 Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia Status COMPLETED Phase PHASE3
NCT00037219 The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis. Status COMPLETED Phase PHASE2
NCT00037206 A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA). Status COMPLETED Phase PHASE2/PHASE3
NCT00037180 For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy Status TERMINATED Phase PHASE2
NCT00037050 Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria Status COMPLETED Phase PHASE3